SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-23-042970
Filing Date
2023-11-29
Accepted
2023-11-28 18:35:33
Documents
16

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 1023277
2 form424b5_001.jpg GRAPHIC 18752
3 form424b5_011.jpg GRAPHIC 81154
4 form424b5_012.jpg GRAPHIC 81154
5 form424b5_004.jpg GRAPHIC 18986
6 form424b5_005.jpg GRAPHIC 24777
7 form424b5_013.jpg GRAPHIC 14816
8 form424b5_007.jpg GRAPHIC 11388
9 form424b5_008.jpg GRAPHIC 5374
10 form424b5_009.jpg GRAPHIC 115060
11 form424b5_014.jpg GRAPHIC 85483
12 form424b5_002.jpg GRAPHIC 50831
13 form424b5_003.jpg GRAPHIC 64383
14 form424b5_016.jpg GRAPHIC 64757
15 form424b5_015.jpg GRAPHIC 91711
16 form424b5_010.jpg GRAPHIC 4202
  Complete submission text file 0001493152-23-042970.txt   2035470
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275350 | Film No.: 231447972
SIC: 2834 Pharmaceutical Preparations